Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. MyMD Pharmaceuticals Inc.’s current trading price is -83.35% away from its 52-week high, while its distance from the 52-week low is -5.72%. The stock’s price range over this period has fluctuated between $0.65 and $3.68. The company, operating within the financial sector, had a trading volume of approximately 0.94 million for the day, which was noticeably higher than the average daily share volume of 0.73 million over the last 3 months.
The present stock price for MyMD Pharmaceuticals Inc. (MYMD) is $0.61. In the last trading session, the stock made a considerable jump, reaching $0.72 after an opening price of $0.70. The stock briefly fell to $0.6004 before ending the session at $0.70.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
MyMD Pharmaceuticals Inc. experienced a rather shaky stock market performance. The highest value in the past year was recorded at $3.68 on 09/16/22 and the lowest value was $0.65 on 09/15/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
MyMD Pharmaceuticals Inc. (MYMD) has experienced a quarterly decline of -62.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 31.49M and boasts a workforce of 9 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4290, with a change in price of -1.0872. Similarly, MyMD Pharmaceuticals Inc. recorded 649,190 in trading volume during the last 100 days, posting a change of -63.95%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MYMD stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
MYMD Stock Stochastic Average
Today’s raw stochastic average for MyMD Pharmaceuticals Inc. over the last 50 days is 0.81%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 2.07%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 5.31% and 5.66%, respectively.
MYMD Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price loss of -46.71% this year. Over the last six months, there has been a stronger performance of -67.58%. The price of MYMD leaped by -45.77% during the last 30 days period. For the last 5-days stocks have slided -16.05%.
